跳至主要内容
临床试验/NCT04454125
NCT04454125已完成不适用

Air Quality Index (AQI) and Childhood Asthma: an Intervention

University of Pittsburgh2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年7月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Number of Participants With at Least One Moderate or Severe Asthma Exacerbation Over Time

研究概览

简要总结

This is a small pilot prospective intervention trial in children with asthma who will be randomized to receive either (A) Air Quality Index (AQI) education + an asthma action plan (control) or (B) AQI education + an asthma action plan which contains AQI behavioral recommendations + demonstrate ability to navigate to AirNow either online or on smartphone app (intervention).

详细描述

Over 3 million US children with asthma reported at least one attack in the prior year. Poorly controlled asthma is a major cause of suffering, school absences, loss of caregiver productivity, and healthcare costs (estimated as ~$80 billion/year). Over half of children on controller medication are not well controlled, due to environmental exposures, non-adherence, or true non-response to treatment. Outdoor air pollution is a known trigger of asthma. Although sound health policies are the best long-term approaches to reduce the harmful effects of air pollution, exposure avoidance is needed until "clean air" is ensured through effective legislation. Despite this, healthcare providers infrequently provide pollution exposure advice to children with asthma. The Environmental Protection Agency (EPA) monitors air pollution and reports a daily Air Quality Index (AQI) that is easy to use and available in most metropolitan areas. Practical recommendations regarding outdoor activity can be based on AQI levels. Despite this, AQI-based recommendations are rarely addressed in asthma action plans (AAP). No pediatric study has assessed the addition of the AQI to AAP to reduce asthma morbidity. This proposal seeks to recruit a pilot cohort of 40 children with asthma. Using this cohort, the investigators will test the hypotheses that (1) the addition of the AQI to AAP will reduce asthma exacerbations and (2) the addition of the AQI to AAP will improve asthma symptom control & quality of life in children with asthma. The inclusion of the AQI onto asthma action plans is novel in clinical asthma care; its wide availability would make large-scale implementation feasible. The investigators expect this low-cost and low-tech intervention will have a positive impact in reducing asthma morbidity. Given that 1 out of every 12 children in the U.S. has asthma, this is relevant to health care professionals, parents, and public health practitioners.

Optional, the investigators will collect nasal epithelial cells for use in future genomic/epigenetic studies.

Additionally, 40 parents/guardians of the children were also recruited to complete a baseline parental knowledge and usage of the AQI questionnaire administered at the randomization visit. This was originally listed as a secondary outcome however was removed during reporting of results as parental knowledge is not a true clinical trial outcome. Also, the secondary outcome of baseline child AQI usage (checking AQI) was changed to reflect this was a measure collected at all study visits and the secondary measure of physical activity was added.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

Unblinded

入排标准

年龄范围
8 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Child Inclusion criteria includes:
  • physician diagnosis of persistent asthma- either mild, moderate, or severe;
  • family home internet access and/or smartphone access + willingness to download AirNow app on phone;
  • age 8-17 years.
  • Parent/guardian inclusion: parent or guardian of the child participant, of whom has met inclusion criteria.

排除标准

  • Child exclusion criteria includes:
  • diagnosis of other chronic respiratory disease (e.g. cystic fibrosis, bronchopulmonary dysplasia, etc)
  • immunodeficiency- acquired or congenital
  • neuromuscular disease
  • disability affecting ambulation
  • cyanotic congenital heart disease
  • only 1 child per household eligible
  • no plans to leave Pittsburgh area in next 6 months
  • Parental/guardian exclusion criteria: none.

结局指标

主要结局

Number of Participants With at Least One Moderate or Severe Asthma Exacerbation Over Time

时间窗: Over study duration (up to 6 months)

Moderate and severe asthma exacerbations were captured via questionnaire administered monthly for up to 6 months. Severe and moderate exacerbations were defined by American Thoracic Society (ATS) criteria.

Mean Change in Pediatric Asthma Quality of Life Over Time

时间窗: Baseline, 6 months

Quality of life will be measured by the validated Pediatric Asthma Quality of Life Questionnaire with standardized activities (PAQLQ) at entrance and exit visits. Differences in PAQLQ scores will be compared both within arms and between arms at study end. PAQLQ (min=1 (extremely bothered/all the time), max=7 (not bothered/none of the time)

Mean Change in Asthma Control Over Time

时间窗: Over study duration (up to 6 months)

Asthma symptom control was measured by the validated Asthma Control Test (ACT) or Childhood Asthma Control Test (CACT) questionnaires as age appropriate (ACT in children 12 year of age or older; CACT for children younger than 12 years of age). ACT and CACT were obtained at baseline and every 4 weeks for up to 6 months. Differences in asthma control scores were compared both within arms and between arms at study end. ACT (min=5, max=25, score of \<=19 concerning for poor asthma control; \<=15 concerning for very poorly controlled). CACT (min=0, max=27, score of \<=19 concerning for poor asthma control; \<=12 concerning for very poorly controlled)

次要结局

  • Number of Participated Who Reported Outdoor Activity Behavioral Change in Response to the AQI(Over study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.)
  • Number of Participants Who Reported Checking the AQI Prior to Going Outside to be Active(Over study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.)
  • Number of Participants Who Reported Moderate or Vigorous Physical Activity for at Least 10 Minutes Continuously Outside in a Typical Week(Over study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Franziska Rosser, MD MPH

Assistant Professor of Pediatrics

University of Pittsburgh

研究点 (2)

Loading locations...

相似试验